RL Smith

695 total citations
21 papers, 521 citations indexed

About

RL Smith is a scholar working on Pharmacology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, RL Smith has authored 21 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 3 papers in Molecular Biology and 3 papers in Clinical Biochemistry. Recurrent topics in RL Smith's work include Pharmacogenetics and Drug Metabolism (4 papers), Metabolism and Genetic Disorders (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). RL Smith is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Metabolism and Genetic Disorders (3 papers) and Amino Acid Enzymes and Metabolism (2 papers). RL Smith collaborates with scholars based in United Kingdom, United States and Czechia. RL Smith's co-authors include C.L. Wilcox, EM Johnson, Richard Lancaster, Jeffrey R. Idle, R. T. Williams, Sergio Fabro, A. Mahgoub, L. G. Dring, Adriana Huyer and John Church and has published in prestigious journals such as Journal of Neuroscience, The Journal of Immunology and British Journal of Clinical Pharmacology.

In The Last Decade

RL Smith

19 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RL Smith United Kingdom 11 184 111 110 105 58 21 521
L. Tryphonas Canada 22 417 2.3× 62 0.6× 221 2.0× 58 0.6× 37 0.6× 43 1.1k
Satoru Chiba Japan 17 295 1.6× 42 0.4× 24 0.2× 47 0.4× 103 1.8× 101 965
Tetsuo Matsui Japan 13 383 2.1× 125 1.1× 100 0.9× 20 0.2× 35 0.6× 25 884
J. R. Hansbrough United States 14 266 1.4× 65 0.6× 135 1.2× 11 0.1× 90 1.6× 18 908
A C Gough United Kingdom 10 390 2.1× 119 1.1× 126 1.1× 197 1.9× 94 1.6× 15 890
Norichika A. Okada United States 5 224 1.2× 146 1.3× 38 0.3× 17 0.2× 53 0.9× 6 664
Ryan M. Pelis United States 18 279 1.5× 66 0.6× 58 0.5× 69 0.7× 37 0.6× 39 1.0k
Michael J. Boulware United States 15 214 1.2× 167 1.5× 58 0.5× 45 0.4× 69 1.2× 22 1.2k
Wenjie Wu United States 17 276 1.5× 48 0.4× 98 0.9× 9 0.1× 105 1.8× 33 735
Stephen S. Goldman United States 14 362 2.0× 31 0.3× 88 0.8× 19 0.2× 35 0.6× 19 630

Countries citing papers authored by RL Smith

Since Specialization
Citations

This map shows the geographic impact of RL Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RL Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RL Smith more than expected).

Fields of papers citing papers by RL Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RL Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RL Smith. The network helps show where RL Smith may publish in the future.

Co-authorship network of co-authors of RL Smith

This figure shows the co-authorship network connecting the top 25 collaborators of RL Smith. A scholar is included among the top collaborators of RL Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RL Smith. RL Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smith, RL. (2011). Libraries and word of mouth marketing. Durham Research Online (Durham University). 1 indexed citations
2.
Smith, RL. (2001). The Paton Prize Award. The discovery of the debrisoquine hydroxylation polymorphism: scientific and clinical impact and consequences.. PubMed. 168(1). 11–9. 14 indexed citations
3.
Shatters, Robert G., et al.. (1995). Effect of transition interval between melting and annealing temperatures on RAPD analyses.. PubMed. 19(1). 38, 40–2. 25 indexed citations
4.
Smith, RL, et al.. (1995). Central venous catheter infection rates in an acute care hospital.. PubMed. 18(5). 255–62. 2 indexed citations
6.
Sutton, Mark A., et al.. (1993). Modelling the net exchange of reduced nitrogen. 125–139. 4 indexed citations
7.
Ayesh, R., H. Kroemer, Michel Eichelbaum, & RL Smith. (1991). Metabolism of verapamil in a family pedigree with deficient N‐oxidation of trimethylamine.. British Journal of Clinical Pharmacology. 31(6). 693–696. 3 indexed citations
8.
Wilcox, C.L., et al.. (1990). Nerve growth factor-dependence of herpes simplex virus latency in peripheral sympathetic and sensory neurons in vitro. Journal of Neuroscience. 10(4). 1268–1275. 121 indexed citations
9.
Smith, RL, et al.. (1989). Use of restriction fragment-length polymorphism (RFLP) markers in genetics and breeding of napiergrass.. Europe PMC (PubMed Central). 48. 13–19. 3 indexed citations
10.
Smith, RL, et al.. (1989). Think you're powerless? Think again.. PubMed. 19(11). 103–4, 107. 1 indexed citations
11.
Huyer, Adriana, et al.. (1988). Currents off south-eastern Australia: results from the Australian coastal experiment. Marine and Freshwater Research. 39(3). 245–288. 46 indexed citations
12.
Smith, RL, et al.. (1985). Type II collagen-reactive T cell clones from mice with collagen-induced arthritis. The Journal of Immunology. 135(4). 2904–2904. 2 indexed citations
13.
Kong, In Deok, et al.. (1983). The contribution of genetically determined oxidation status to inter‐ individual variation in phenacetin disposition.. British Journal of Clinical Pharmacology. 16(2). 157–166. 33 indexed citations
14.
Idle, Jeffrey R., et al.. (1980). Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]. British Journal of Clinical Pharmacology. 9(1). 112P–113P. 2 indexed citations
15.
Mucklow, JC, et al.. (1980). The influence of changes in dietary fat on the clearance of antipyrine and 4‐hydroxylation of debrisoquine.. British Journal of Clinical Pharmacology. 9(3). 283P–283P. 12 indexed citations
16.
Idle, Jeffrey R., et al.. (1979). The metabolism of [14C]‐debrisoquine in man.. British Journal of Clinical Pharmacology. 7(3). 257–266. 59 indexed citations
17.
Caldwell, John, Richard Lancaster, T J Monks, & RL Smith. (1977). The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline [proceedings]. British Journal of Clinical Pharmacology. 4(5). 637P–638P. 33 indexed citations
18.
Smith, RL. (1972). Capital financing: is philanthropy dead?. PubMed. 46(5). 91–6. 1 indexed citations
19.
Fabro, Sergio, RL Smith, & R. T. Williams. (1967). The fate of[14C]thalidomide in the pregnant rabbit. Biochemical Journal. 104(2). 565–569. 21 indexed citations
20.
Fabro, Sergio, RL Smith, & R. T. Williams. (1967). The fate of the hydrolysis products of thalidomide in the pregnant rabbit. Biochemical Journal. 104(2). 570–574. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026